Viridian Therapeutics, Inc.
VRDN
$17.90
$0.512.93%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
Viridian Therapeutics (VRDN, $17.85) Stochastic Oscillator left the overbought zone on June 26, 2026
6/27/2026
-
Tickeron - Stocks
6/26/2026
-
TipRanks: TheFly
6/26/2026
-
GuruFocus
6/26/2026
-
Business Wire
Viridian Therapeutics (VRDN, $17.34) Stochastic Oscillator left the overbought zone on June 24, 2026
6/26/2026
-
Tickeron - Stocks
6/25/2026
-
TipRanks
6/25/2026
-
MarketBeat
6/25/2026
-
SeekingAlpha
6/25/2026
-
Seeking Alpha - Healthcare
Viridian Therapeutics (VRDN, $17.63) Stochastic Oscillator left the overbought zone on June 22, 2026
6/23/2026
-
Tickeron - Stocks
6/21/2026
-
Simply Wall St
6/19/2026
-
Simply Wall St
6/18/2026
-
MarketBeat
6/18/2026
-
MarketBeat
6/18/2026
-
MarketBeat
6/18/2026
-
Tickeron - Stocks
6/17/2026
-
TipRanks
6/17/2026
-
MarketBeat
6/17/2026
-
Tickeron - Stocks
6/10/2026
-
SeekingAlpha
6/10/2026
-
Seeking Alpha: Transcripts
6/7/2026
-
Simply Wall St
6/6/2026
-
Tickeron - Stocks
6/5/2026
-
Tickeron - Stocks
6/4/2026
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, May 5, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 272 4600
Address
221 Crescent Street
Waltham, MA 02453
Waltham, MA 02453
Country
Year Founded
Business Description
Sector
Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. It develops IGF-1R therapies to treat thyroid eye disease (TED)...
more